Suppr超能文献

冠状动脉疾病患者体内氧化应激指标8-异前列腺素血浆水平升高的证据。

Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease.

作者信息

Vassalle Cristina, Botto Nicoletta, Andreassi Maria Grazia, Berti Sergio, Biagini Andrea

机构信息

CNR Institute of Clinical Physiology, Via Moruzzi 1, I-56100 Pisa, Italy.

出版信息

Coron Artery Dis. 2003 May;14(3):213-8. doi: 10.1097/01.mca.0000063504.13456.c3.

Abstract

BACKGROUND

It is well known that free radicals contribute to endothelial dysfunction and are involved in ageing and in the pathogenesis and development of many cardiovascular diseases, such as atherosclerosis. Measurement of F(2)-isoprostanes has emerged as probably the most reliable approach to assess oxidative stress status in vivo. In particular, 8-isoprostane (8-epiPGF(2alpha)) has been indicated as a marker of antioxidant deficiency and oxidative stress of potential relevance to assess human vascular diseases.

DESIGN

To provide evidence for enhanced oxidative stress in coronary artery disease (CAD).

METHODS

Plasma levels of 8-epiPGF(2alpha) (EIA, Cayman Chemicals, Ann Arbor, Michigan, USA) were measured in 51 patients (19 females, 32 males, age: 58.7+/-1.6 years, mean+/-SEM). Subjects included 13 healthy control subjects (group I), and 38 patients underwent coronary angiography; 11 patients without coronary artery atherosclerotic lesions (group II), and 27 with angiographically proven CAD (group III).

RESULTS

Plasma levels of 8-epiPGF(2alpha) were 123.2+/-9.5, 314.6+/-40 and 389.6+/-36.2 pg/ml in groups I, II and III respectively (P<0.05 and P<0.001 groups II and III versus group I, respectively). In group III, 8-epiPGF(2alpha) levels increased with the number of affected vessels (324.4+/-47.2 and 408.3+/-44.1 pg/ml for one- and multi-vessel disease, P=0.07 and P<0.001 versus control subjects, respectively). A significant difference in 8-epiPGF(2alpha) levels was observed between patients with and without hypertension (394.2+/-42.7 and 232.7+/-25.1 pg/ml, P<0.01, respectively). In addition, patients with dyslipidaemia presented higher 8-epiPGF(2alpha) levels with respect to non-dyslipidaemic patients (359.1+/-35.6 and 240.3+/-34.3 pg/ml, P<0.05, respectively). A positive relationship was found between age and 8-epiPGF(2alpha) levels (r=0.42, P<0.01) in the whole population.

CONCLUSION

These findings indicate that elevated levels of plasma 8-epiPGF(2alpha) levels are associated with the extent and the severity of coronary artery disease and with the occurrence of different atherogenic risk factors, supporting the hypothesis that the evaluation of oxidative stress may represent an additional prognostic predictor in such events and a potential target of future therapeutic interventions.

摘要

背景

众所周知,自由基会导致内皮功能障碍,并参与衰老以及许多心血管疾病(如动脉粥样硬化)的发病机制和发展过程。F(2)-异前列腺素的测量已成为评估体内氧化应激状态最可靠的方法。特别是,8-异前列腺素(8-表前列腺素F(2α))已被视为一种抗氧化剂缺乏和氧化应激的标志物,可能与评估人类血管疾病相关。

设计

为冠状动脉疾病(CAD)中氧化应激增强提供证据。

方法

测量了51例患者(19名女性,32名男性,年龄:58.7±1.6岁,平均值±标准误)血浆中8-表前列腺素F(2α)的水平(酶免疫分析法,美国密歇根州安阿伯市开曼化学公司)。受试者包括13名健康对照者(第一组),以及38例行冠状动脉造影的患者;11例无冠状动脉粥样硬化病变的患者(第二组),以及27例经血管造影证实患有CAD的患者(第三组)。

结果

第一组、第二组和第三组血浆中8-表前列腺素F(2α)的水平分别为123.2±9.5、314.6±40和389.6±36.2 pg/ml(第二组和第三组与第一组相比,P<0.05和P<0.001)。在第三组中,8-表前列腺素F(2α)水平随受累血管数量增加而升高(单支血管病变和多支血管病变分别为324.4±47.2和408.3±44.1 pg/ml,与对照者相比,P=0.07和P<0.001)。有高血压和无高血压患者的8-表前列腺素F(2α)水平存在显著差异(分别为394.2±42.7和232.7±25.1 pg/ml,P<0.01)。此外,血脂异常患者的8-表前列腺素F(2α)水平高于非血脂异常患者(分别为359.1±35.6和240.3±34.3 pg/ml,P<0.05)。在整个人群中,年龄与8-表前列腺素F(2α)水平呈正相关(r=0.42,P<0.01)。

结论

这些发现表明,血浆8-表前列腺素F(2α)水平升高与冠状动脉疾病的范围和严重程度以及不同致动脉粥样硬化危险因素的发生相关,支持氧化应激评估可能是此类事件中一个额外的预后预测指标以及未来治疗干预潜在靶点的假说。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验